Calcium Channel Blocker [EPC]

Calcium Channel Blocker [EPC] was reported 328392 times

Drugs of the Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NON-CARDIOGENIC PULMONARY OEDEMA 365 0.3450
1 DISTRIBUTIVE SHOCK 766 0.3379
2 VASOPLEGIA SYNDROME 530 0.3230
3 GINGIVAL HYPERTROPHY 461 0.3037
4 HYPERPARATHYROIDISM SECONDARY 547 0.2181
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 221 0.2081
6 NEPHROGENIC ANAEMIA 962 0.2075
7 CAROTID ARTERY THROMBOSIS 165 0.1943
8 BRASH SYNDROME 255 0.1816
9 SUSPECTED SUICIDE 786 0.1676
10 BLOOD PRESSURE SYSTOLIC ABNORMAL 333 0.1346
11 ADJUSTMENT DISORDER 167 0.1285
12 BLOOD PRESSURE DIASTOLIC ABNORMAL 310 0.1218
13 REBOUND ACID HYPERSECRETION 347 0.1146
14 PHYSICAL DECONDITIONING 291 0.1130
15 END STAGE RENAL DISEASE 1990 0.1090
16 SEDATION COMPLICATION 272 0.1065
17 CREATININE RENAL CLEARANCE DECREASED 325 0.0811
18 SHOCK 1794 0.0779
19 BLOOD PRESSURE INADEQUATELY CONTROLLED 453 0.0752
20 DIASTOLIC DYSFUNCTION 232 0.0751
21 PERSONALITY DISORDER 194 0.0740
22 BLOOD PRESSURE SYSTOLIC INCREASED 1437 0.0736
23 LEFT VENTRICULAR HYPERTROPHY 312 0.0728
24 HYPOMAGNESAEMIA 1004 0.0720
25 CHRONIC KIDNEY DISEASE 5426 0.0713
26 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 174 0.0703
27 ORTHOSTATIC HYPOTENSION 1211 0.0695
28 ATRIOVENTRICULAR BLOCK FIRST DEGREE 299 0.0689
29 BREATH SOUNDS ABNORMAL 337 0.0683
30 METABOLIC ACIDOSIS 2169 0.0678
31 COMPLETED SUICIDE 5565 0.0667
32 ACUTE KIDNEY INJURY 9963 0.0650
33 CARDIOGENIC SHOCK 933 0.0650
34 APLASTIC ANAEMIA 336 0.0643
35 BLOOD PRESSURE DIASTOLIC DECREASED 470 0.0636
36 HYPERTENSIVE CRISIS 682 0.0612
37 POTENTIATING DRUG INTERACTION 200 0.0595
38 GINGIVAL SWELLING 258 0.0584
39 HAEMODYNAMIC INSTABILITY 443 0.0581
40 TUBULOINTERSTITIAL NEPHRITIS 1079 0.0575
41 LACTIC ACIDOSIS 1845 0.0569
42 HYPERKALAEMIA 1980 0.0564
43 ATRIOVENTRICULAR BLOCK COMPLETE 374 0.0558
44 BLOOD LACTIC ACID INCREASED 293 0.0556
45 BENIGN PROSTATIC HYPERPLASIA 283 0.0547
46 RALES 316 0.0544
47 INTENTIONAL OVERDOSE 3463 0.0539
48 AORTIC STENOSIS 188 0.0539
49 HYPONATRAEMIA 2984 0.0529
50 OLIGURIA 324 0.0521
51 BRADYCARDIA 2765 0.0521
52 BLOOD PRESSURE FLUCTUATION 1233 0.0513
53 PROTEIN URINE PRESENT 256 0.0513
54 HYPOKALAEMIA 2362 0.0511
55 ANURIA 440 0.0511
56 SINUS BRADYCARDIA 485 0.0501
57 BLOOD PRESSURE DIASTOLIC INCREASED 231 0.0500
58 NOCTURIA 604 0.0497
59 BRONCHIECTASIS 332 0.0492
60 RENAL FUNCTION TEST ABNORMAL 226 0.0486
61 GLOMERULAR FILTRATION RATE DECREASED 595 0.0484
62 CAROTID ARTERY STENOSIS 167 0.0478
63 HYPERVOLAEMIA 236 0.0477
64 HYPERURICAEMIA 196 0.0476
65 BLOOD CALCIUM DECREASED 530 0.0471
66 BODY TEMPERATURE DECREASED 461 0.0468
67 OBSTRUCTIVE AIRWAYS DISORDER 519 0.0466
68 RENAL TUBULAR NECROSIS 457 0.0465
69 CUTANEOUS VASCULITIS 168 0.0460
70 CIRCULATORY COLLAPSE 779 0.0457
71 PEMPHIGOID 344 0.0455
72 BLOOD URIC ACID INCREASED 263 0.0455
73 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 181 0.0443
74 RENAL INJURY 1314 0.0442
75 DYSPNOEA EXERTIONAL 1664 0.0441
76 BLOOD MAGNESIUM DECREASED 380 0.0440
77 HYPOTENSION 8784 0.0437
78 IRON DEFICIENCY 195 0.0433
79 HYPOVOLAEMIA 253 0.0432
80 BUNDLE BRANCH BLOCK LEFT 183 0.0431
81 ARTERIAL OCCLUSIVE DISEASE 339 0.0431
82 BLOOD PRESSURE SYSTOLIC DECREASED 196 0.0430
83 PULSELESS ELECTRICAL ACTIVITY 180 0.0430
84 BLOOD PRESSURE INCREASED 6540 0.0427
85 KIDNEY TRANSPLANT REJECTION 205 0.0427
86 HYPOCALCAEMIA 804 0.0424
87 GINGIVAL PAIN 338 0.0424
88 BLOOD CREATININE INCREASED 2771 0.0424
89 HEMIPLEGIA 349 0.0419
90 GOUT 751 0.0418
91 HYPOVOLAEMIC SHOCK 200 0.0417
92 HAEMORRHAGIC ANAEMIA 183 0.0416
93 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 425 0.0414
94 VASCULITIS 481 0.0412
95 ACIDOSIS 315 0.0412
96 PROTEINURIA 776 0.0408
97 BUNDLE BRANCH BLOCK RIGHT 187 0.0407
98 MAJOR DEPRESSION 296 0.0405
99 RENAL FAILURE 5340 0.0402
100 SPRUE-LIKE ENTEROPATHY 198 0.0401
101 HEART RATE DECREASED 1410 0.0401
102 TROPONIN INCREASED 305 0.0400
103 DIVERTICULUM INTESTINAL 175 0.0400
104 PULMONARY OEDEMA 1791 0.0400
105 UPPER GASTROINTESTINAL HAEMORRHAGE 670 0.0398
106 ANGINA PECTORIS 1133 0.0395
107 HYPOTHERMIA 399 0.0394
108 DRUG INTERACTION 6237 0.0393
109 TOXICITY TO VARIOUS AGENTS 6621 0.0392
110 RENAL IMPAIRMENT 3298 0.0392
111 DRUG LEVEL INCREASED 649 0.0392
112 HYPERCALCAEMIA 484 0.0392
113 HAIR DISORDER 322 0.0390
114 GANGRENE 235 0.0390
115 ISCHAEMIA 179 0.0389
116 HAIR COLOUR CHANGES 484 0.0389
117 CARDIAC FAILURE ACUTE 259 0.0388
118 HYPERTENSION 8235 0.0388
119 MICTURITION URGENCY 441 0.0386
120 RENAL CYST 304 0.0382
121 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 338 0.0382
122 OEDEMA PERIPHERAL 4623 0.0379
123 HYPOPHOSPHATAEMIA 280 0.0378
124 URINE OUTPUT DECREASED 331 0.0378
125 NEPHROPATHY 351 0.0376
126 GINGIVAL BLEEDING 512 0.0375
127 NEPHROTIC SYNDROME 257 0.0375
128 ABNORMAL LOSS OF WEIGHT 255 0.0374
129 CORONARY ARTERY STENOSIS 188 0.0373
130 HYPOXIA 1316 0.0373
131 FULL BLOOD COUNT ABNORMAL 395 0.0373
132 SEROTONIN SYNDROME 716 0.0372
133 GINGIVITIS 201 0.0372
134 NEUTROPENIC SEPSIS 266 0.0372
135 ACUTE RESPIRATORY FAILURE 715 0.0371
136 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 190 0.0370
137 INTESTINAL ISCHAEMIA 204 0.0370
138 ELECTROLYTE IMBALANCE 430 0.0370
139 RHINITIS 297 0.0368
140 HYPERKERATOSIS 203 0.0368
141 ERYSIPELAS 184 0.0366
142 SWOLLEN TONGUE 1141 0.0365
143 BLOOD UREA INCREASED 611 0.0365
144 MYOPATHY 314 0.0363
145 RHABDOMYOLYSIS 1512 0.0362
146 ANGIOEDEMA 1597 0.0361
147 ACUTE MYOCARDIAL INFARCTION 1064 0.0360
148 BLOOD POTASSIUM INCREASED 583 0.0359
149 YELLOW SKIN 168 0.0358
150 JOINT SWELLING 4330 0.0358
151 UROSEPSIS 330 0.0357
152 COLITIS MICROSCOPIC 169 0.0356
153 PERIPHERAL SWELLING 5443 0.0353
154 BLOOD PRESSURE ABNORMAL 702 0.0353
155 SPUTUM DISCOLOURED 334 0.0352
156 HYPERLIPIDAEMIA 419 0.0350
157 ATRIOVENTRICULAR BLOCK 270 0.0349
158 MITRAL VALVE INCOMPETENCE 395 0.0349
159 ATRIAL FLUTTER 278 0.0348
160 BLOOD POTASSIUM DECREASED 1037 0.0345
161 HEMIPARESIS 584 0.0344
162 DIZZINESS POSTURAL 334 0.0344
163 ACUTE CORONARY SYNDROME 284 0.0343
164 EXERCISE TOLERANCE DECREASED 197 0.0342
165 SENSORY LOSS 275 0.0341
166 BLOOD SODIUM DECREASED 643 0.0341
167 HYPERCHOLESTEROLAEMIA 329 0.0340
168 HYPERGLYCAEMIA 1238 0.0339
169 RENAL CELL CARCINOMA 166 0.0339
170 COLITIS ISCHAEMIC 227 0.0336
171 POLYURIA 275 0.0335
172 MELAENA 736 0.0334
173 LEUKOCYTOSIS 604 0.0333
174 POLYP 218 0.0333
175 CARDIAC MURMUR 287 0.0331
176 FLUID OVERLOAD 482 0.0331
177 RENAL FAILURE CHRONIC 254 0.0330
178 ELECTROCARDIOGRAM ABNORMAL 259 0.0330
179 BASAL CELL CARCINOMA 514 0.0329
180 LARGE INTESTINE POLYP 228 0.0329
181 IRON DEFICIENCY ANAEMIA 302 0.0327
182 CARDIOMEGALY 402 0.0326
183 HYPOGLYCAEMIA 1581 0.0326
184 SUBDURAL HAEMATOMA 466 0.0325
185 ATRIAL FIBRILLATION 3166 0.0325
186 SINUS CONGESTION 439 0.0325
187 OEDEMA 1752 0.0323
188 TASTE DISORDER 654 0.0322
189 RESPIRATORY RATE INCREASED 286 0.0322
190 OXYGEN SATURATION DECREASED 1804 0.0321
191 ACUTE RESPIRATORY DISTRESS SYNDROME 567 0.0320
192 SUICIDE ATTEMPT 1935 0.0319
193 PSYCHOLOGICAL TRAUMA 274 0.0317
194 SPINAL OSTEOARTHRITIS 278 0.0316
195 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 302 0.0316
196 BLOOD IRON DECREASED 375 0.0316
197 TRANSFUSION 331 0.0316
198 PRODUCTIVE COUGH 1505 0.0315
199 ARTERIOSCLEROSIS 296 0.0314
200 WHEEZING 1864 0.0314
201 LIP SWELLING 1046 0.0314
202 FAECES SOFT 228 0.0313
203 ARTERIOSCLEROSIS CORONARY ARTERY 207 0.0312
204 SKIN ULCER 802 0.0310
205 COORDINATION ABNORMAL 432 0.0309
206 HAEMODIALYSIS 260 0.0309
207 GENERALISED OEDEMA 383 0.0309
208 LOWER GASTROINTESTINAL HAEMORRHAGE 228 0.0308
209 DIABETES MELLITUS INADEQUATE CONTROL 545 0.0308
210 GROIN PAIN 270 0.0307
211 MYASTHENIA GRAVIS 248 0.0307
212 ACUTE PULMONARY OEDEMA 172 0.0306
213 PAROSMIA 231 0.0306
214 DEPRESSED LEVEL OF CONSCIOUSNESS 1206 0.0305
215 GLUCOSE TOLERANCE IMPAIRED 180 0.0304
216 BOWEL MOVEMENT IRREGULARITY 233 0.0304
217 RENAL FAILURE ACUTE 1289 0.0303
218 CLOSTRIDIUM DIFFICILE COLITIS 322 0.0303
219 PLEURAL EFFUSION 1846 0.0303
220 SUBARACHNOID HAEMORRHAGE 309 0.0303
221 CORONARY ARTERY OCCLUSION 416 0.0303
222 TRANSIENT ISCHAEMIC ATTACK 1023 0.0303
223 HYDRONEPHROSIS 227 0.0303
224 ELECTROCARDIOGRAM QT PROLONGED 1085 0.0301
225 ANAL INCONTINENCE 271 0.0301
226 LEFT VENTRICULAR DYSFUNCTION 201 0.0300
227 FLANK PAIN 281 0.0299
228 DIVERTICULUM 212 0.0298
229 RED BLOOD CELL SEDIMENTATION RATE INCREASED 330 0.0298
230 HIATUS HERNIA 386 0.0298
231 ANGIOPATHY 166 0.0296
232 MULTIPLE ORGAN DYSFUNCTION SYNDROME 838 0.0296
233 PROSTATIC SPECIFIC ANTIGEN INCREASED 407 0.0295
234 MENTAL STATUS CHANGES 820 0.0295
235 SYNCOPE 2947 0.0294
236 NEPHROPATHY TOXIC 330 0.0294
237 FAECES DISCOLOURED 636 0.0293
238 BLOOD PRESSURE DECREASED 1948 0.0293
239 BODY HEIGHT DECREASED 313 0.0292
240 TRICUSPID VALVE INCOMPETENCE 232 0.0292
241 DUODENAL ULCER 206 0.0292
242 ATELECTASIS 282 0.0292
243 VENTRICULAR EXTRASYSTOLES 303 0.0291
244 DYSARTHRIA 1098 0.0291
245 AORTIC ANEURYSM 221 0.0290
246 IMPAIRED QUALITY OF LIFE 415 0.0288
247 TACHYPNOEA 392 0.0288
248 HEART RATE IRREGULAR 651 0.0288
249 IMPAIRED GASTRIC EMPTYING 392 0.0287
250 EXTRASYSTOLES 200 0.0286
251 HEPATIC STEATOSIS 533 0.0286
252 POLLAKIURIA 1193 0.0286
253 URINE ODOUR ABNORMAL 168 0.0285
254 BLOOD URINE PRESENT 542 0.0285
255 BLOOD ALBUMIN DECREASED 226 0.0285
256 OESOPHAGITIS 311 0.0284
257 HAEMORRHAGIC STROKE 222 0.0284
258 HAIR TEXTURE ABNORMAL 379 0.0283
259 ISCHAEMIC STROKE 503 0.0282
260 ANGINA UNSTABLE 183 0.0281
261 PANCREATITIS ACUTE 632 0.0281
262 ERECTILE DYSFUNCTION 722 0.0281
263 PNEUMONIA ASPIRATION 702 0.0281
264 MOTOR DYSFUNCTION 286 0.0280
265 CEREBRAL INFARCTION 685 0.0280
266 PETECHIAE 292 0.0280
267 HAEMATOCRIT DECREASED 554 0.0279
268 UPPER-AIRWAY COUGH SYNDROME 230 0.0279
269 PULMONARY HYPERTENSION 581 0.0279
270 BALANCE DISORDER 2410 0.0279
271 ALTERED STATE OF CONSCIOUSNESS 604 0.0279
272 ORAL PAIN 622 0.0278
273 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1445 0.0277
274 SLEEP APNOEA SYNDROME 528 0.0276
275 RESPIRATORY FAILURE 2017 0.0276
276 MUSCULOSKELETAL CHEST PAIN 428 0.0276
277 HAEMOGLOBIN DECREASED 2838 0.0276
278 PERIPHERAL COLDNESS 379 0.0276
279 BLOOD COUNT ABNORMAL 418 0.0275
280 TOXIC EPIDERMAL NECROLYSIS 418 0.0275
281 PERICARDIAL EFFUSION 636 0.0275
282 EMPHYSEMA 277 0.0274
283 DELIRIUM 952 0.0274
284 DRUG ERUPTION 486 0.0274
285 THROMBOTIC MICROANGIOPATHY 267 0.0274
286 MUSCLE SPASTICITY 336 0.0273
287 HAEMATEMESIS 693 0.0273
288 PULMONARY CONGESTION 360 0.0273
289 ADRENAL INSUFFICIENCY 330 0.0272
290 SHOCK HAEMORRHAGIC 221 0.0271
291 MADAROSIS 315 0.0271
292 EOSINOPHILIA 475 0.0271
293 DEHYDRATION 3611 0.0270
294 LETHARGY 1557 0.0270
295 CHOLESTASIS 519 0.0270
296 OSTEOARTHRITIS 1145 0.0270
297 C-REACTIVE PROTEIN INCREASED 982 0.0270
298 PULMONARY MASS 401 0.0269
299 URINARY RETENTION 895 0.0268
300 FALL 8927 0.0268
301 RED BLOOD CELL COUNT DECREASED 762 0.0266
302 HYPOPHAGIA 681 0.0266
303 HAEMOGLOBIN ABNORMAL 171 0.0266
304 ECCHYMOSIS 182 0.0265
305 HAEMORRHOIDS 512 0.0262
306 RECTAL HAEMORRHAGE 1126 0.0262
307 LYMPHOEDEMA 181 0.0261
308 CONFUSIONAL STATE 4222 0.0261
309 EATING DISORDER 556 0.0261
310 DYSURIA 961 0.0261
311 MYOCARDIAL ISCHAEMIA 297 0.0261
312 DECREASED APPETITE 6060 0.0261
313 URINARY INCONTINENCE 772 0.0260
314 HALLUCINATION, VISUAL 548 0.0259
315 INTERNATIONAL NORMALISED RATIO INCREASED 740 0.0259
316 FLUID RETENTION 1320 0.0259
317 ASCITES 761 0.0259
318 ANAEMIA 4931 0.0258
319 RENAL DISORDER 1199 0.0257
320 PRESYNCOPE 625 0.0257
321 PULMONARY ARTERIAL HYPERTENSION 372 0.0256
322 PURPURA 227 0.0256
323 CONSTIPATION 5595 0.0256
324 HAEMATURIA 878 0.0256
325 MYOSITIS 230 0.0256
326 HOSPICE CARE 253 0.0256
327 CYSTITIS 813 0.0255
328 COVID-19 PNEUMONIA 301 0.0255
329 HAEMOPTYSIS 711 0.0255
330 GASTROINTESTINAL HAEMORRHAGE 2130 0.0255
331 PARKINSONISM 248 0.0254
332 HAEMATOMA 658 0.0254
333 CORONARY ARTERY DISEASE 769 0.0254
334 SINUS TACHYCARDIA 360 0.0253
335 VITAMIN D DECREASED 216 0.0252
336 UNRESPONSIVE TO STIMULI 651 0.0252
337 HYPERTHYROIDISM 365 0.0252
338 CELLULITIS 1269 0.0252
339 ARTHRITIS 1976 0.0251
340 VENTRICULAR FIBRILLATION 279 0.0251
341 MOUTH HAEMORRHAGE 184 0.0251
342 SUPRAVENTRICULAR TACHYCARDIA 240 0.0250
343 GAMMA-GLUTAMYLTRANSFERASE INCREASED 554 0.0250
344 INCREASED TENDENCY TO BRUISE 230 0.0250
345 PAPULE 176 0.0250
346 ENCEPHALOPATHY 613 0.0249
347 SEASONAL ALLERGY 353 0.0249
348 INTERSTITIAL LUNG DISEASE 1205 0.0249
349 GASTROENTERITIS 363 0.0248
350 MOUTH ULCERATION 523 0.0248
351 CARDIAC ARREST 2048 0.0248
352 MUSCULAR WEAKNESS 2819 0.0248
353 PYELONEPHRITIS 214 0.0247
354 HYPOALBUMINAEMIA 192 0.0247
355 PALPITATIONS 2884 0.0246
356 GASTROOESOPHAGEAL REFLUX DISEASE 1982 0.0246
357 SECRETION DISCHARGE 308 0.0246
358 INTERNAL HAEMORRHAGE 281 0.0246
359 CATARACT 1462 0.0245
360 SQUAMOUS CELL CARCINOMA 231 0.0245
361 GASTRIC ULCER 466 0.0245
362 APHTHOUS ULCER 190 0.0245
363 PNEUMONIA 7926 0.0245
364 HYPOKINESIA 355 0.0244
365 CARDIOTOXICITY 218 0.0244
366 RESPIRATORY TRACT CONGESTION 388 0.0244
367 PNEUMONIA BACTERIAL 224 0.0244
368 DRY MOUTH 1979 0.0244
369 EPISTAXIS 1824 0.0244
370 DYSPNOEA 13793 0.0243
371 BACTERAEMIA 289 0.0243
372 APHASIA 734 0.0243
373 CARDIAC FAILURE 1951 0.0243
374 SMALL INTESTINAL OBSTRUCTION 299 0.0243
375 NEURALGIA 590 0.0242
376 CHEST PAIN 4484 0.0242
377 GASTRITIS 637 0.0242
378 AGEUSIA 603 0.0241
379 BLOOD CALCIUM INCREASED 212 0.0241
380 DIVERTICULITIS 669 0.0241
381 HYPOTHYROIDISM 769 0.0241
382 ULCER 383 0.0241
383 EJECTION FRACTION DECREASED 374 0.0240
384 URINARY TRACT INFECTION 4103 0.0240
385 COUGH 6738 0.0240
386 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 560 0.0240
387 PELVIC FRACTURE 187 0.0240
388 BLOOD CREATINE PHOSPHOKINASE INCREASED 689 0.0239
389 ORAL DISORDER 175 0.0238
390 MUSCULOSKELETAL DISCOMFORT 409 0.0237
391 RIGHT VENTRICULAR FAILURE 166 0.0237
392 SINUS DISORDER 469 0.0237
393 THIRST 423 0.0237
394 HAEMATOCHEZIA 1305 0.0236
395 POOR QUALITY SLEEP 509 0.0236
396 PLATELET COUNT INCREASED 308 0.0236
397 SWELLING FACE 1537 0.0236
398 FEELING COLD 657 0.0236
399 AFFECT LABILITY 227 0.0236
400 VITAMIN D DEFICIENCY 230 0.0236
401 GLAUCOMA 454 0.0236
402 ASTHENIA 8855 0.0235
403 MUSCLE ATROPHY 298 0.0235
404 SPINAL PAIN 275 0.0234
405 CHROMATURIA 529 0.0234
406 LOWER RESPIRATORY TRACT INFECTION 1065 0.0234
407 RENAL PAIN 248 0.0234
408 CONTUSION 2251 0.0234
409 PULMONARY FIBROSIS 448 0.0233
410 AGRANULOCYTOSIS 434 0.0233
411 ABNORMAL FAECES 191 0.0233
412 MYALGIA 3959 0.0233
413 BLOOD THYROID STIMULATING HORMONE INCREASED 214 0.0232
414 HEAD INJURY 734 0.0232
415 RESPIRATORY DISTRESS 640 0.0232
416 FLATULENCE 1314 0.0231
417 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1112 0.0231
418 SPINAL COMPRESSION FRACTURE 191 0.0231
419 PHARYNGEAL SWELLING 226 0.0231
420 LUNG INFILTRATION 204 0.0231
421 FEBRILE NEUTROPENIA 1532 0.0231
422 DIARRHOEA 14883 0.0230
423 WHITE BLOOD CELL COUNT INCREASED 884 0.0230
424 MUSCULOSKELETAL PAIN 1205 0.0230
425 CHEST DISCOMFORT 2354 0.0230
426 TINNITUS 1056 0.0230
427 PAIN IN JAW 651 0.0230
428 FACIAL PAIN 205 0.0229
429 LIMB DISCOMFORT 710 0.0229
430 DISORIENTATION 908 0.0229
431 MYOCLONUS 273 0.0229
432 SEPSIS 2545 0.0228
433 RESPIRATORY TRACT INFECTION 593 0.0227
434 DIALYSIS 323 0.0227
435 HEAD DISCOMFORT 402 0.0227
436 COGNITIVE DISORDER 1058 0.0226
437 BLOOD TEST ABNORMAL 318 0.0226
438 DIZZINESS 11284 0.0226
439 HEPATOMEGALY 222 0.0226
440 CHOLECYSTITIS 269 0.0226
441 DECREASED ACTIVITY 243 0.0225
442 ARRHYTHMIA 1066 0.0225
443 HAEMORRHAGE INTRACRANIAL 336 0.0224
444 NEUTROPHIL COUNT INCREASED 230 0.0224
445 BLISTER 1259 0.0224
446 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 174 0.0224
447 RASH MACULO-PAPULAR 498 0.0224
448 WEIGHT DECREASED 6230 0.0223
449 CEREBRAL HAEMORRHAGE 798 0.0223
450 ILEUS 277 0.0223
451 CARDIO-RESPIRATORY ARREST 932 0.0223
452 INTERVERTEBRAL DISC DEGENERATION 206 0.0222
453 DRY THROAT 226 0.0222
454 FULL BLOOD COUNT DECREASED 448 0.0222
455 MEDICATION ERROR 1235 0.0222
456 SNEEZING 498 0.0222
457 DYSSTASIA 648 0.0222
458 ASPIRATION 243 0.0222
459 MOBILITY DECREASED 1594 0.0222
460 HOT FLUSH 1671 0.0221
461 LOCAL SWELLING 386 0.0221
462 VERTIGO 1346 0.0221
463 RIB FRACTURE 454 0.0220
464 SKIN LESION 605 0.0220
465 VENTRICULAR TACHYCARDIA 364 0.0220
466 CHOKING 430 0.0220
467 SCIATICA 350 0.0219
468 ABDOMINAL PAIN 5106 0.0219
469 PAIN IN EXTREMITY 6467 0.0219
470 SKIN HAEMORRHAGE 325 0.0219
471 SKIN LACERATION 237 0.0218
472 DYSPEPSIA 2140 0.0217
473 MUCOSAL INFLAMMATION 569 0.0217
474 ORAL CANDIDIASIS 286 0.0217
475 CLOSTRIDIUM DIFFICILE INFECTION 474 0.0217
476 DYSPHAGIA 2058 0.0217
477 PNEUMONITIS 590 0.0216
478 GENERAL PHYSICAL HEALTH DETERIORATION 2504 0.0216
479 GAIT DISTURBANCE 4137 0.0216
480 BLOOD ALKALINE PHOSPHATASE INCREASED 536 0.0216
481 ROTATOR CUFF SYNDROME 277 0.0215
482 FREQUENT BOWEL MOVEMENTS 582 0.0215
483 HEART RATE INCREASED 2133 0.0215
484 CHOLELITHIASIS 706 0.0215
485 MUSCLE SPASMS 3949 0.0215
486 DYSPHONIA 1254 0.0214
487 GLYCOSYLATED HAEMOGLOBIN INCREASED 541 0.0214
488 DECUBITUS ULCER 174 0.0213
489 NECK PAIN 1192 0.0213
490 PRODUCT PRESCRIBING ERROR 508 0.0213
491 PNEUMOCYSTIS JIROVECII PNEUMONIA 214 0.0213
492 FATIGUE 16580 0.0213
493 ESCHERICHIA INFECTION 175 0.0213
494 LOSS OF CONSCIOUSNESS 2725 0.0212
495 ASTHMA 2399 0.0212
496 ANHEDONIA 557 0.0212
497 RHINORRHOEA 1367 0.0211
498 VITREOUS FLOATERS 207 0.0210
499 PLATELET COUNT DECREASED 2244 0.0210
500 DYSGEUSIA 1563 0.0210
501 METASTASES TO LUNG 243 0.0210
502 LOCALISED INFECTION 508 0.0210
503 MALNUTRITION 235 0.0210
504 RASH PRURITIC 1138 0.0210
505 POISONING DELIBERATE 199 0.0210
506 TOXIC SKIN ERUPTION 210 0.0208
507 STENT PLACEMENT 168 0.0208
508 ABDOMINAL DISTENSION 2170 0.0208
509 COAGULOPATHY 346 0.0207
510 ASPARTATE AMINOTRANSFERASE INCREASED 1102 0.0207
511 WEIGHT FLUCTUATION 217 0.0207
512 ALANINE AMINOTRANSFERASE INCREASED 1272 0.0207
513 NERVE COMPRESSION 191 0.0207
514 TOOTH INFECTION 272 0.0206
515 PRURITUS GENERALISED 446 0.0206
516 PANCYTOPENIA 1151 0.0206
517 PARAESTHESIA ORAL 297 0.0206
518 THYROID DISORDER 317 0.0205
519 BACK PAIN 4768 0.0205
520 OROPHARYNGEAL PAIN 1896 0.0205
521 LIVER FUNCTION TEST ABNORMAL 595 0.0204
522 DRUG-INDUCED LIVER INJURY 641 0.0204
523 TACHYCARDIA 1814 0.0204
524 FACIAL PARALYSIS 174 0.0204
525 SPLENOMEGALY 239 0.0204
526 PALLOR 555 0.0204
527 SLEEP DISORDER 1438 0.0204
528 BLOOD LACTATE DEHYDROGENASE INCREASED 322 0.0203
529 CARDIAC FAILURE CONGESTIVE 1632 0.0203
530 HEPATOCELLULAR INJURY 288 0.0203
531 EAR DISCOMFORT 208 0.0202
532 INTERVERTEBRAL DISC PROTRUSION 443 0.0202
533 HALLUCINATION 1525 0.0202
534 NASAL CONGESTION 1189 0.0202
535 JAUNDICE 543 0.0202
536 INCONTINENCE 212 0.0200
537 HEPATIC FUNCTION ABNORMAL 748 0.0200
538 EOSINOPHIL COUNT INCREASED 167 0.0200
539 JOINT INJURY 427 0.0200
540 SKIN DISCOLOURATION 918 0.0200
541 DIABETES MELLITUS 1519 0.0199
542 BLINDNESS UNILATERAL 281 0.0199
543 DIPLOPIA 517 0.0199
544 TUMOUR LYSIS SYNDROME 175 0.0199
545 KIDNEY INFECTION 390 0.0199
546 MIDDLE INSOMNIA 371 0.0198
547 FEEDING DISORDER 402 0.0198
548 ABDOMINAL DISCOMFORT 3319 0.0198
549 MALIGNANT MELANOMA 265 0.0198
550 VOMITING 9272 0.0197
551 BRAIN FOG 309 0.0197
552 POOR VENOUS ACCESS 204 0.0197
553 INFUSION SITE ERYTHEMA 166 0.0197
554 SKIN PLAQUE 166 0.0197
555 SEDATION 515 0.0196
556 COLITIS 745 0.0196
557 STEVENS-JOHNSON SYNDROME 436 0.0196
558 EXOSTOSIS 179 0.0196
559 TOOTH FRACTURE 216 0.0196
560 THROAT IRRITATION 875 0.0195
561 HIP FRACTURE 627 0.0195
562 NIGHT SWEATS 628 0.0195
563 ARTHRALGIA 8073 0.0194
564 MUSCLE STRAIN 167 0.0193
565 INTENTIONAL PRODUCT USE ISSUE 1690 0.0193
566 DIABETIC KETOACIDOSIS 463 0.0193
567 APPENDICITIS 180 0.0193
568 PULMONARY THROMBOSIS 210 0.0192
569 TOOTH ABSCESS 196 0.0192
570 BACTERIAL INFECTION 359 0.0192
571 BRONCHITIS 1423 0.0192
572 HEPATIC ENCEPHALOPATHY 179 0.0192
573 LIMB INJURY 521 0.0192
574 MUSCULOSKELETAL STIFFNESS 1679 0.0191
575 DIARRHOEA HAEMORRHAGIC 179 0.0191
576 ATAXIA 227 0.0191
577 OSTEOPENIA 290 0.0191
578 STOMATITIS 1157 0.0191
579 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 323 0.0190
580 JOINT DISLOCATION 201 0.0190
581 MALAISE 8337 0.0190
582 COLD SWEAT 335 0.0190
583 PHARYNGEAL OEDEMA 292 0.0190
584 BLOOD GLUCOSE FLUCTUATION 208 0.0190
585 ECONOMIC PROBLEM 287 0.0189
586 OSTEOPOROSIS 779 0.0189
587 SWELLING 1766 0.0189
588 FEELING HOT 1156 0.0188
589 PHOTOSENSITIVITY REACTION 311 0.0188
590 CEREBROVASCULAR ACCIDENT 3187 0.0188
591 APATHY 274 0.0188
592 ABDOMINAL PAIN UPPER 3866 0.0188
593 HYPERSOMNIA 538 0.0187
594 CONTRAINDICATED PRODUCT ADMINISTERED 567 0.0187
595 LIVER FUNCTION TEST INCREASED 402 0.0187
596 LUNG DISORDER 915 0.0187
597 COLON CANCER 278 0.0186
598 NEUROPATHY PERIPHERAL 1774 0.0186
599 BLADDER DISORDER 185 0.0186
600 BLOOD BILIRUBIN INCREASED 503 0.0186
601 SOMNOLENCE 3748 0.0186
602 CANDIDA INFECTION 314 0.0186
603 BLOOD CHOLESTEROL INCREASED 866 0.0186
604 RETCHING 396 0.0186
605 METASTASES TO LIVER 326 0.0185
606 INFLUENZA 2068 0.0185
607 GAIT INABILITY 619 0.0185
608 MUSCLE TIGHTNESS 300 0.0185
609 OBESITY 295 0.0185
610 NEPHROLITHIASIS 849 0.0185
611 INFLAMMATION 955 0.0185
612 NIGHTMARE 638 0.0184
613 DEMENTIA 515 0.0184
614 SEPTIC SHOCK 800 0.0184
615 EYE HAEMORRHAGE 245 0.0183
616 MASS 256 0.0183
617 DEPRESSED MOOD 967 0.0183
618 ANKLE FRACTURE 283 0.0183
619 TENDERNESS 190 0.0182
620 CARPAL TUNNEL SYNDROME 255 0.0182
621 PARAESTHESIA 2859 0.0182
622 MOVEMENT DISORDER 583 0.0181
623 JOINT STIFFNESS 476 0.0181
624 PNEUMOTHORAX 286 0.0180
625 GENERALISED TONIC-CLONIC SEIZURE 298 0.0180
626 MYOCARDITIS 206 0.0180
627 ERUCTATION 347 0.0179
628 THROMBOCYTOPENIA 2004 0.0179
629 EYELID OEDEMA 208 0.0179
630 APHONIA 249 0.0178
631 NAUSEA 14112 0.0178
632 TENDONITIS 276 0.0178
633 LIGAMENT SPRAIN 176 0.0178
634 HERNIA 343 0.0177
635 VISION BLURRED 2424 0.0176
636 BURSITIS 214 0.0176
637 BLOOD GLUCOSE ABNORMAL 325 0.0176
638 RESTLESSNESS 643 0.0176
639 TREMOR 2916 0.0176
640 DISSEMINATED INTRAVASCULAR COAGULATION 247 0.0175
641 COMA 833 0.0175
642 DRUG LEVEL DECREASED 178 0.0175
643 GASTROINTESTINAL PAIN 192 0.0174
644 BLOOD TRIGLYCERIDES INCREASED 308 0.0174
645 INTESTINAL OBSTRUCTION 657 0.0174
646 SARS-COV-2 TEST POSITIVE 230 0.0174
647 CYTOPENIA 212 0.0173
648 BURNING SENSATION 1214 0.0173
649 INFUSION SITE PAIN 223 0.0173
650 HYPOAESTHESIA 2587 0.0173
651 NERVE INJURY 192 0.0173
652 BRAIN OEDEMA 218 0.0172
653 TYPE 2 DIABETES MELLITUS 581 0.0172
654 PULMONARY EMBOLISM 1640 0.0172
655 TREATMENT NONCOMPLIANCE 942 0.0172
656 RESTLESS LEGS SYNDROME 313 0.0172
657 PYREXIA 5948 0.0172
658 TENDON RUPTURE 212 0.0172
659 PRESCRIBED UNDERDOSE 342 0.0171
660 LYMPHOCYTE COUNT DECREASED 303 0.0171
661 TOOTH DISORDER 380 0.0171
662 HERPES ZOSTER 981 0.0171
663 INSOMNIA 4547 0.0171
664 WOUND 476 0.0170
665 DEVICE RELATED INFECTION 262 0.0170
666 PHARYNGITIS 211 0.0170
667 ORAL DISCOMFORT 236 0.0170
668 EAR PAIN 330 0.0170
669 LACRIMATION INCREASED 511 0.0169
670 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 435 0.0169
671 NASOPHARYNGITIS 3115 0.0169
672 IMMUNODEFICIENCY 251 0.0168
673 CHILLS 1973 0.0168
674 EYE INFECTION 190 0.0168
675 PRODUCT ADMINISTRATION ERROR 340 0.0168
676 QUALITY OF LIFE DECREASED 225 0.0168
677 HEPATITIS 429 0.0167
678 UPPER LIMB FRACTURE 334 0.0167
679 LYMPHOPENIA 237 0.0167
680 MACULAR DEGENERATION 200 0.0167
681 OSTEOMYELITIS 303 0.0167
682 RASH MACULAR 585 0.0167
683 SENSORY DISTURBANCE 268 0.0167
684 DISTURBANCE IN ATTENTION 900 0.0167
685 HEADACHE 10429 0.0166
686 COVID-19 2914 0.0166
687 TRANSAMINASES INCREASED 369 0.0166
688 ARTHROPATHY 922 0.0166
689 PANCREATITIS 876 0.0166
690 SPEECH DISORDER 864 0.0165
691 INCREASED APPETITE 315 0.0165
692 BACK DISORDER 268 0.0165
693 EYE SWELLING 613 0.0165
694 WHITE BLOOD CELL COUNT DECREASED 1785 0.0165
695 BONE PAIN 961 0.0164
696 AMNESIA 1064 0.0163
697 FLUSHING 1661 0.0163
698 POISONING 205 0.0163
699 BREAST PAIN 174 0.0163
700 ABDOMINAL PAIN LOWER 412 0.0163
701 SLUGGISHNESS 166 0.0163
702 SKIN INFECTION 182 0.0162
703 PRURITUS 6231 0.0162
704 NEOPLASM 186 0.0162
705 MALIGNANT NEOPLASM PROGRESSION 1653 0.0161
706 RESPIRATORY ARREST 444 0.0161
707 MUSCLE TWITCHING 371 0.0161
708 DELUSION 250 0.0161
709 LUNG INFECTION 250 0.0161
710 LIVER DISORDER 713 0.0161
711 POST PROCEDURAL HAEMORRHAGE 187 0.0160
712 INTESTINAL PERFORATION 180 0.0160
713 SINUSITIS 1643 0.0160
714 SCRATCH 169 0.0160
715 WRIST FRACTURE 192 0.0160
716 HEPATIC CIRRHOSIS 300 0.0159
717 CYST 198 0.0159
718 NEUTROPHIL COUNT DECREASED 650 0.0159
719 NODULE 208 0.0159
720 MEMORY IMPAIRMENT 2186 0.0159
721 BEDRIDDEN 209 0.0159
722 PLASMA CELL MYELOMA 620 0.0159
723 LYMPHADENOPATHY 562 0.0159
724 THERAPY CESSATION 815 0.0159
725 BLOOD GLUCOSE DECREASED 762 0.0159
726 ANXIETY 4510 0.0158
727 DRUG INTOLERANCE 1526 0.0158
728 PHOTOPHOBIA 297 0.0158
729 GASTROENTERITIS VIRAL 285 0.0158
730 DISCOMFORT 962 0.0158
731 DEEP VEIN THROMBOSIS 1024 0.0157
732 DEAFNESS 412 0.0157
733 CONDITION AGGRAVATED 4789 0.0157
734 LIVER INJURY 386 0.0157
735 NERVOUSNESS 821 0.0157
736 INFUSION RELATED REACTION 1041 0.0157
737 WEIGHT INCREASED 3513 0.0157
738 PAIN 9620 0.0156
739 HYPERHIDROSIS 2015 0.0156
740 BONE DISORDER 285 0.0156
741 BODY TEMPERATURE INCREASED 319 0.0156
742 WOUND INFECTION 171 0.0156
743 TOOTHACHE 282 0.0156
744 THERAPY INTERRUPTED 1113 0.0156
745 FOOT FRACTURE 295 0.0155
746 SKIN CANCER 334 0.0155
747 THROMBOSIS 1246 0.0155
748 SPINAL FRACTURE 310 0.0155
749 DERMATITIS 324 0.0154
750 UPPER RESPIRATORY TRACT INFECTION 714 0.0154
751 DISEASE RECURRENCE 732 0.0154
752 EYE PAIN 868 0.0154
753 ALOPECIA 3018 0.0154
754 OVERDOSE 3313 0.0153
755 ORAL HERPES 299 0.0153
756 VISUAL IMPAIRMENT 1896 0.0153
757 FACE OEDEMA 258 0.0153
758 INTENTIONAL DOSE OMISSION 436 0.0153
759 ACCIDENTAL OVERDOSE 559 0.0153
760 HEPATIC ENZYME INCREASED 1041 0.0153
761 RESPIRATORY DISORDER 456 0.0152
762 RASH 6629 0.0152
763 KNEE ARTHROPLASTY 320 0.0152
764 SCAB 173 0.0152
765 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 260 0.0152
766 OCULAR DISCOMFORT 170 0.0151
767 FEELING ABNORMAL 3627 0.0151
768 POLYNEUROPATHY 181 0.0151
769 CARDIOMYOPATHY 223 0.0151
770 RASH ERYTHEMATOUS 720 0.0150
771 DEPRESSION 3408 0.0150
772 FOOT DEFORMITY 166 0.0150
773 MUSCLE RIGIDITY 179 0.0150
774 INTENTIONAL PRODUCT MISUSE 1310 0.0149
775 PRODUCT DOSE OMISSION 975 0.0149
776 HYPOAESTHESIA ORAL 225 0.0149
777 CYTOKINE RELEASE SYNDROME 299 0.0149
778 VIRAL INFECTION 496 0.0149
779 SCAR 255 0.0149
780 GLOSSODYNIA 333 0.0149
781 SPINAL OPERATION 183 0.0148
782 MUSCULOSKELETAL DISORDER 282 0.0148
783 PARALYSIS 212 0.0148
784 SKIN EXFOLIATION 1249 0.0148
785 BLINDNESS 603 0.0148
786 ABSCESS 236 0.0148
787 GASTROINTESTINAL DISORDER 1325 0.0148
788 POST PROCEDURAL COMPLICATION 284 0.0148
789 GASTRIC HAEMORRHAGE 170 0.0148
790 SKIN DISORDER 491 0.0147
791 HEPATOTOXICITY 326 0.0146
792 JOINT RANGE OF MOTION DECREASED 196 0.0146
793 BLOOD GLUCOSE INCREASED 2753 0.0146
794 ANOSMIA 211 0.0146
795 RASH GENERALISED 377 0.0145
796 PRODUCT SUBSTITUTION ISSUE 837 0.0145
797 SYNOVITIS 262 0.0145
798 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1028 0.0144
799 DERMATITIS ALLERGIC 181 0.0144
800 FEMUR FRACTURE 445 0.0144
801 CARDIAC DISORDER 1336 0.0143
802 PSORIASIS 1856 0.0142
803 NEUROTOXICITY 249 0.0142
804 ANAPHYLACTIC REACTION 785 0.0142
805 HEPATIC CYTOLYSIS 181 0.0142
806 NEUROLEPTIC MALIGNANT SYNDROME 168 0.0142
807 INTRAOCULAR PRESSURE INCREASED 181 0.0141
808 STAPHYLOCOCCAL INFECTION 467 0.0141
809 EYE DISORDER 465 0.0141
810 MULTI-ORGAN FAILURE 244 0.0141
811 EYE PRURITUS 473 0.0141
812 DYSKINESIA 572 0.0141
813 CONJUNCTIVITIS 261 0.0141
814 LABORATORY TEST ABNORMAL 415 0.0140
815 THERAPY NON-RESPONDER 631 0.0140
816 PRODUCT TASTE ABNORMAL 190 0.0140
817 AGITATION 1030 0.0140
818 FUNGAL INFECTION 467 0.0140
819 RASH PAPULAR 313 0.0140
820 FRACTURE 264 0.0139
821 BRONCHOSPASM 199 0.0139
822 IMPAIRED HEALING 456 0.0139
823 HIP ARTHROPLASTY 212 0.0138
824 INFECTION 2003 0.0138
825 EPILEPSY 423 0.0138
826 DISEASE PROGRESSION 1637 0.0138
827 HEPATIC FAILURE 417 0.0138
828 SEIZURE 1594 0.0138
829 MYOCARDIAL INFARCTION 2406 0.0138
830 OFF LABEL USE 12065 0.0138
831 FEELING JITTERY 261 0.0137
832 THROAT TIGHTNESS 370 0.0137
833 ERYTHEMA 2803 0.0136
834 HYPOACUSIS 587 0.0136
835 RHEUMATOID ARTHRITIS 1544 0.0136
836 TOOTH EXTRACTION 169 0.0136
837 NEOPLASM PROGRESSION 472 0.0136
838 VISUAL ACUITY REDUCED 450 0.0135
839 ECZEMA 705 0.0135
840 ANAPHYLACTIC SHOCK 346 0.0134
841 PERITONITIS 277 0.0134
842 NEUTROPENIA 1817 0.0133
843 LEUKOPENIA 668 0.0133
844 HAEMORRHAGE 1392 0.0133
845 PRODUCT DISPENSING ERROR 289 0.0133
846 EYE IRRITATION 760 0.0132
847 CYANOSIS 207 0.0131
848 CYTOMEGALOVIRUS INFECTION 218 0.0131
849 ILLNESS 1348 0.0131
850 GASTRIC DISORDER 448 0.0130
851 PRODUCT USE COMPLAINT 205 0.0130
852 IMPAIRED WORK ABILITY 278 0.0130
853 PRODUCT DOSE OMISSION IN ERROR 368 0.0130
854 INFLUENZA LIKE ILLNESS 1064 0.0129
855 METASTASES TO BONE 212 0.0129
856 ABASIA 319 0.0129
857 HALLUCINATION, AUDITORY 205 0.0129
858 DRY EYE 638 0.0128
859 GALLBLADDER DISORDER 228 0.0128
860 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2284 0.0127
861 OCULAR HYPERAEMIA 596 0.0125
862 ABNORMAL DREAMS 344 0.0124
863 LOWER LIMB FRACTURE 238 0.0124
864 PROCEDURAL PAIN 342 0.0123
865 OSTEONECROSIS OF JAW 305 0.0123
866 MENTAL IMPAIRMENT 295 0.0122
867 COLITIS ULCERATIVE 542 0.0121
868 FIBROMYALGIA 294 0.0121
869 PRODUCT USE ISSUE 2254 0.0120
870 SYSTEMIC LUPUS ERYTHEMATOSUS 425 0.0120
871 PSORIATIC ARTHROPATHY 485 0.0119
872 SKIN REACTION 168 0.0119
873 DRUG PRESCRIBING ERROR 228 0.0119
874 ROAD TRAFFIC ACCIDENT 496 0.0118
875 EAR INFECTION 314 0.0118
876 PRESCRIBED OVERDOSE 228 0.0118
877 MYELODYSPLASTIC SYNDROME 170 0.0117
878 URTICARIA 1969 0.0117
879 HYPERSENSITIVITY 2172 0.0117
880 ACTIVITIES OF DAILY LIVING IMPAIRED 230 0.0116
881 PERICARDITIS 195 0.0116
882 SKIN FISSURES 226 0.0116
883 PRODUCT PHYSICAL ISSUE 233 0.0115
884 THINKING ABNORMAL 214 0.0115
885 IRRITABLE BOWEL SYNDROME 246 0.0115
886 PANIC ATTACK 417 0.0114
887 MOOD ALTERED 311 0.0114
888 UNEVALUABLE EVENT 861 0.0114
889 MENTAL DISORDER 494 0.0113
890 CARDIOVASCULAR DISORDER 288 0.0113
891 BONE MARROW FAILURE 229 0.0113
892 HOSPITALISATION 1724 0.0112
893 MANIA 184 0.0112
894 PRODUCT USE IN UNAPPROVED INDICATION 2743 0.0111
895 THERAPEUTIC PRODUCT EFFECT DECREASED 493 0.0110
896 MIGRAINE 1038 0.0109
897 ADVERSE DRUG REACTION 975 0.0108
898 DRY SKIN 1447 0.0108
899 MULTIPLE FRACTURES 178 0.0108
900 FEAR 291 0.0108
901 PRODUCT DOSE OMISSION ISSUE 3127 0.0106
902 PRODUCT AVAILABILITY ISSUE 239 0.0105
903 INCORRECT PRODUCT ADMINISTRATION DURATION 227 0.0105
904 PAIN OF SKIN 282 0.0105
905 DRUG DOSE OMISSION 1729 0.0104
906 THERAPEUTIC RESPONSE UNEXPECTED 466 0.0104
907 PARANOIA 178 0.0103
908 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 721 0.0101
909 SURGERY 591 0.0101
910 DRUG EFFECT INCOMPLETE 366 0.0101
911 PSYCHOMOTOR HYPERACTIVITY 167 0.0101
912 LUNG NEOPLASM MALIGNANT 409 0.0099
913 NERVOUS SYSTEM DISORDER 310 0.0099
914 SUICIDAL IDEATION 909 0.0099
915 ILL-DEFINED DISORDER 602 0.0099
916 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 543 0.0099
917 NEEDLE ISSUE 286 0.0098
918 TOOTH LOSS 203 0.0098
919 PSYCHOTIC DISORDER 289 0.0098
920 INJECTION SITE MASS 361 0.0098
921 DRUG INEFFECTIVE 12850 0.0097
922 DEATH 8167 0.0095
923 EXTRAPYRAMIDAL DISORDER 235 0.0095
924 PRODUCT PRESCRIBING ISSUE 205 0.0094
925 ANGER 314 0.0093
926 EXPIRED PRODUCT ADMINISTERED 308 0.0093
927 UNDERDOSE 666 0.0091
928 ABNORMAL BEHAVIOUR 360 0.0091
929 THERAPEUTIC RESPONSE SHORTENED 300 0.0090
930 PRODUCT QUALITY ISSUE 1226 0.0090
931 THERAPEUTIC RESPONSE DECREASED 542 0.0089
932 EMOTIONAL DISORDER 274 0.0089
933 EMOTIONAL DISTRESS 1068 0.0088
934 APPLICATION SITE PRURITUS 195 0.0086
935 BONE DENSITY DECREASED 269 0.0086
936 INCORRECT DOSE ADMINISTERED 1952 0.0085
937 AGGRESSION 425 0.0085
938 WITHDRAWAL SYNDROME 350 0.0083
939 INCORRECT DRUG ADMINISTRATION DURATION 234 0.0083
940 CRYING 299 0.0082
941 IRRITABILITY 492 0.0082
942 INTENTIONAL DRUG MISUSE 171 0.0082
943 DRUG ADMINISTRATION ERROR 251 0.0082
944 ADVERSE EVENT 748 0.0081
945 NEOPLASM MALIGNANT 535 0.0080
946 MOOD SWINGS 251 0.0079
947 PREMATURE BABY 236 0.0078
948 DRUG EFFECT DECREASED 405 0.0075
949 EXTRA DOSE ADMINISTERED 300 0.0074
950 PANCREATIC CARCINOMA 210 0.0073
951 INJECTION SITE BRUISING 576 0.0072
952 WRONG TECHNIQUE IN DRUG USAGE PROCESS 262 0.0072
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1461 0.0072
954 INJECTION SITE HAEMORRHAGE 561 0.0070
955 DEVICE DELIVERY SYSTEM ISSUE 192 0.0070
956 CONVULSION 399 0.0070
957 DERMATITIS ATOPIC 362 0.0069
958 DRUG RESISTANCE 176 0.0068
959 DEVICE ISSUE 612 0.0068
960 DEVICE MALFUNCTION 479 0.0068
961 TREATMENT FAILURE 554 0.0067
962 ACNE 500 0.0066
963 INJURY 458 0.0065
964 APPLICATION SITE ERYTHEMA 170 0.0065
965 VAGINAL HAEMORRHAGE 275 0.0063
966 INJECTION SITE PRURITUS 418 0.0062
967 DRUG ABUSE 513 0.0062
968 MULTIPLE SCLEROSIS RELAPSE 413 0.0060
969 INJECTION SITE PAIN 1828 0.0060
970 TARDIVE DYSKINESIA 166 0.0059
971 INJECTION SITE SWELLING 445 0.0058
972 SKIN BURNING SENSATION 416 0.0058
973 SKIN IRRITATION 257 0.0056
974 MULTIPLE SCLEROSIS 267 0.0056
975 OSTEONECROSIS 183 0.0056
976 FOETAL EXPOSURE DURING PREGNANCY 432 0.0053
977 PROSTATE CANCER 420 0.0052
978 PRODUCT ADHESION ISSUE 185 0.0052
979 INJECTION SITE ERYTHEMA 637 0.0051
980 INJECTION SITE REACTION 336 0.0049
981 DEVICE DISLOCATION 210 0.0048
982 EXPOSURE DURING PREGNANCY 292 0.0047
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 215 0.0046
984 RENAL CANCER 215 0.0045
985 BREAST CANCER 406 0.0044
986 NO ADVERSE EVENT 787 0.0043
987 DEVICE LEAKAGE 180 0.0041
988 ACCIDENTAL EXPOSURE TO PRODUCT 409 0.0040
989 MATERNAL EXPOSURE DURING PREGNANCY 352 0.0039
990 DRUG DOSE OMISSION BY DEVICE 285 0.0036
991 PRODUCT STORAGE ERROR 287 0.0033
992 BLADDER CANCER 188 0.0032
993 DRUG WITHDRAWAL SYNDROME 267 0.0030
994 DRUG DEPENDENCE 225 0.0014